Diabetes Care Market, By Product Type (Glucose Monitoring Devices (Blood glucose monitoring (BGM), Continuous glucose monitoring (CGM), Flash glucose monitoring (FGM)), Insulin Pumps (Patch pump, Tethered pump, Implanted insulin pump, and Others (Insulin

Diabetes Care Market, By Product Type (Glucose Monitoring Devices (Blood glucose monitoring (BGM), Continuous glucose monitoring (CGM), Flash glucose monitoring (FGM)), Insulin Pumps (Patch pump, Tethered pump, Implanted insulin pump, and Others (Insulin Syringes, Pen Needles, etc.)), By Diabetes Type (Type 2 Diabetes, Type 1 Diabetes, and Other (Gestational Diabetes, etc.)), By End User (Hospitals & Clinics, Homecare Settings, Ambulatory Care Settings, and Others (Academic and Research Institutes, Clinical Laboratories, etc.)), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Diabetes is a chronic metabolic disease that affects how the body utilizes glucose. The number of people diagnosed with diabetes has been steadily increasing over the years. In July 2022, according to the International Diabetes Federation, over 537 million adults were living with diabetes in 2021 which is projected to grow to 700 million by 2045. The rising prevalence of the disease has led to an increased demand for diabetes care products and services globally. The diabetes care market covers blood glucose monitoring devices like glucometers, test strips, lancets and monitoring systems, insulin delivery devices like insulin pens, pumps, and injectors, and diabetes management apps and software.

Market Dynamics:

The global diabetes care market growth is driven by the growing diabetes patient pool, increasing awareness about diabetes self-management, advancement of diabetes management technologies, and government initiatives to curb the burden of the disease. However, high device costs, limited medical reimbursement in many countries, and risk of inaccurate readings with some devices restrain the market growth. On the other hand, development of artificial pancreas devices that automatically regulate blood glucose levels, ongoing R&D to develop oral insulin formulations, and islet cell transplantations create lucrative opportunities in the market.

Key Features of the Study:

• This report provides in-depth analysis of the global diabetes care market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global diabetes care market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Medtronic, Abbott, Pumps It, Inc., Embecta Corp, Insulet Corporation, Ypsomed AG, Roche AG, Tandem Diabetes Care, Inc., Terumo, Novo Nordisk A/S, SOOIL Developments Co., Ltd, Microtec Medical Ltd, ViCentra B.V., CeQur Corporation, and Dexcom, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global diabetes care market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetes care market

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2019 - 2031)
• Glucose Monitoring Devices
• Blood glucose monitoring (BGM)
• Continuous glucose monitoring (CGM)
• Flash glucose monitoring (FGM)
• Insulin Pumps
• Patch pump
• Tethered pump
• Implanted insulin pump
• Others (Insulin Syringes, Pen Needles, etc.)
• Diabetes Type Insights (Revenue, USD Bn, 2019 - 2031)
• Type 2 Diabetes
• Type 1 Diabetes
• Other (Gestational Diabetes, etc.)
• End User Insights (Revenue, USD Bn, 2019 - 2031)
• Hospitals & Clinics
• Homecare Settings
• Ambulatory Care Settings
• Others (Academic and Research Institutes, Clinical Laboratories, etc.)
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Key Players Insights
• Medtronic
• Abbott
• Pumps It, Inc.
• Embecta Corp
• Insulet Corporation
• Ypsomed AG
• Roche AG
• Tandem Diabetes Care, Inc.
• Terumo
• Novo Nordisk A/S
• SOOIL Developments Co., Ltd
• Microtec Medical Ltd
• ViCentra B.V.
• CeQur Corporation
• Dexcom, Inc.